Earlier this month documents released in a lawsuit against Monsanto showed how that company drafted articles for various academics. Monsanto said that glyphosate, the main ingredient in Roundup, was safe to use, and Monsanto’s work was published almost word for word in different journals by researchers who had been bought off.
Here is some good news. Today the Times reported that the European Union was looking at an antitrust action against the proposed merger of Bayer and Monsanto. The $56 billion dollar deal would create the largest integrated pesticide and seed company in the world. The U.S. seems to be fine with the merger.
Just as an aside to readers who tell me they get their news from social media, or cable news, or the internet, did any of you see anything about either of these topics? I didn’t think so.
[Information for this post came from two articles: “Monsanto’s Research Sway Is Seen in Disclosed Emails,” New York Times (Aug. 2, 2017), p. B5, and “E.U. Trains Antitrust Magnifying Glass On Plans for an Agricultural Behemoth,” New York Times, (Aug. 23, 2017), p. B3.]
No comments:
Post a Comment